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CA S E R EPO RT
A 65-year-old postmenopausal woman presented with a sixmonth history of fatigue, dyspnoea on exertion and palpitation, which were followed by the onset of a two-month-long generalised purpuric rash and occasional passage of blood in urine. The patient was a normotensive diabetic on oral hypoglycaemic drugs for the past eight years. Her fasting plasma glucose at presentation was 112 mg/dL and her haemoglobin A1c was 5.7%. She had no history of prior blood transfusion, paroxysmal nocturnal dyspnoea, coronary artery disease, cerebrovascular accident, bronchial asthma, collagen vascular diseases or exposure to any known environmental toxins/ allergens. Ten years prior to this presentation, the patient had undergone total abdominal hysterectomy with bilateral salpingo-oophorectomy for uterine fibroid. Physical examination revealed that the patient had marked conjunctival pallor, mild scleral icterus, a blood pressure reading of 124/88 mmHg, generalised purpuric rash and mild splenomegaly (2 cm below the left costal margin). The patient was found to be afebrile.
Systemic evaluation and radiological examinations of the patient's chest and abdomen were not remarkable.
Serial evaluations of the patient's laboratory parameters on admission and during follow-up sessions are presented in Table I . Haemogram findings revealed bicytopenia with an increased reticulocyte count, but no dyspoiesis, blasts or (Fig.1) . Flow cytometric analysis was negative for CD55 and CD59, and urinary haemosiderin test was also negative. Bone marrow morphology, in correlation with the patient's routine haematological and biochemical parameters (raised unconjugated bilirubin, vitamin B 12 , folate, lactate dehydrogenase and ferritin), was suggestive of RCUD.
However, chronic immune thrombocytopenia (ITP) could not be ruled out with certainty.
Peripheral blood G-banding cytogenetics performed at three months post admission showed normal female karyotype (Fig. 2) . FISH analysis was performed on the heparinised bone marrow aspirate sample using the following probes: (a) D20S108 
D I SCU S S IO N
A dominant thrombocytopenic presentation in MDS is rare (3%-7%) and difficult to differentiate from ITP using solely clinical and morphological features; hence, cytogenetic analyses may be necessary. (1, 9) When del(20q12) occurs as a primary or isolated event, it is associated with minimal dysplasia involving erythroid and/or megakaryocytic lineages (morphologically, as RCUD or refractory anaemia with ring sideroblast [RARS]), and a favourable outcome. However, when del(20q12) occurs with one or more cytogenetic abnormalities, it suggests genetic instability, which is featured by the presence of refractory cytopenia multilineage dysplasia, increased blasts with or without transformation, and an increased risk for leukaemic transformation (Table II) . (5) (6) (7) (8) (9) 11) A recent French study (6) retrospectively analysed 98 patients with del(20q). In 62 patients, del(20q) was found to be the sole abnormality, whereas it was associated with other chromosomal abnormalities in the remaining patients. The researchers found that compared to patients with multiple chromosomal abnormalities and patients without del(20q), those with isolated del(20q) had significantly lower platelet counts, fewer (< 5%) blasts in the marrow and higher immature red blood cell counts (higher reticulocyte count). At a median follow-up time of 3.8 years, approximately 14% of patients with isolated del(20q) progressed to AML, compared to 11% Gupta et al, (9) who analysed nine MDS patients with isolated del(20q) and compared them with 17 adult patients with ITP, reported that seven of the nine patients had thrombocytopenia and six had mild anaemia (Hb > 11 g/dL). All nine patients had minimal haematopoietic dysplasia and fewer blasts (< 5%) in the marrow. According to the authors, the identification of del(20q) was crucial to avoid misdiagnosing this entity as ITP.
Another study from China (7) described 29 MDS patients with del(20q) -11 patients had isolated del(20q), while 18 had del(20q) that was associated with other abnormalities. Of the 11 patients with isolated del(20q), 9 were categorised as refractory anaemia (RA)/RARS with breakpoint in 20q11, and two were categorised as refractory anaemia with excess blasts/refractory anaemia with excess blasts in transformation (RAEB/RAEB-t) with breakpoint in 20q12. Additional chromosomal abnormalities and complex karyotype were more frequent in the RAEB/RAEB-t group than the RA/RARS group. Aberrant expression of lymphoid antigens (18%) and trilineage dyspoiesis were important findings in this study. (5, 6, 9) However, there are limitations to FISH, as highlighted by other studies. (13) (14) (15) Clinically, practical FISH strategies are limited to detection of known lesions, and the commercial FISH probe D20S108
may not always distinguish among del(20q), ider(20q) and monosomy 20. (13) FISH adds little, if any, relevant information to adequate routine G-banding cytogenetics. (14) If available, single nucleotide polymorphism array-based karyotyping can reveal unbalanced defects with resolution that is superior to FISH. (15) Apart from the limitations of these techniques, availability and financial constraints are the other major Qin et al, (Table I) . FISH played an instrumental role in confirming the diagnosis, especially when peripheral cytogenetics was inconclusive.
In conclusion, cytogenetic analysis should be an integral component of evaluation in adults with refractory thrombocytopenia, in order to confirm a diagnosis of MDS.
Morbidity and mortality in MDS patients with isolated del(20q) is due to low platelet counts; hence, platelet transfusion should be offered if the patient is symptomatic and transfusion-dependent.
